The Syrian hamster, which can modulate its metabolism as the seasons changes, was the inspiration behind VeroScience's Cycloset, which is used to treat type 2 diabetes.
(istockphoto.com)
A drug's journey from idea to reality
Years of tests, setbacks bridged a curious observation in a hamster and the approval of a diabetes treatment
The Syrian hamster, which can modulate its metabolism as the seasons changes, was the inspiration behind VeroScience's Cycloset, which is used to treat type 2 diabetes.
(istockphoto.com)
TIVERTON, R.I. - Anthony Cincotta hit bottom a little over a decade ago. The biotechnology start-up he had cofounded and built into a publicly traded company was spiraling out of his control. His older brother, Manny, an inspiration and business partner, was fighting leukemia that would soon take his life. And the FDA had just shot down the diabetes drug ... (Full article: 1012 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
